Form 4 for NEO NEOGENOMICS INC
Accepted 2021-07-07 00:00:00 ET · period of report 2021-07-05 · accession 0001077183-21-000186 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-07 | 2021-07-05 | NEO | Wallar Gina M | Pres, Pharma Services | A - Grant | $0.00 | +1,896 | 6,013 | +46% | $0 |
| D | 2021-07-07 | 2021-07-05 | NEO | Wallar Gina M | Pres, Pharma Services | A - Grant | $43.95 | +10.1K | 10.1K | New | +$445.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-05 | A | A | 1,896 | $0.00 | 6,013 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-07-05 | A | A | 10,126 | $43.95 | 10,126 | D | $43.95 · — to 2028-07-05 | 10,126 Common Stock | (F6) On July 5, 2021, Ms. Wallar was granted 10,126 stock options. The options vest ratably over the first four anniversary dates of the grant date. |